When Rac1 is activated, it launches a broad spectrum of downstream pathways and involves in modulating various processes of cancer progression, including cytoskeletal reorganization, migration, invasion and metastasis (Kamai et al., 2010; Myant et al., 2013; Wang et al., 2015). Here, RAC1 is linked to cancer.